Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era

American Heart Journal

Volumn 136, Issue 2, 1998, Pages 245-251

  Haim, Moti ^a   Gottlieb, Shmuel ^a   Boyko, Valentina ^a   Reicher Reiss, Henrietta ^a   Hod, Hanoch ^a   Kaplinsky, Elieser ^a   Mandelzweig, Lori ^a   Goldbourt, Uri ^a   Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; NITRIC ACID DERIVATIVE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY CARE UNIT; FEMALE; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031874224     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1053/hj.1998.v136.90800     Document Type: Article

References (22)

1. Gheorghiade M, Ruzumna P, Borzak S, Havstad S, Abbas A, Goldstein S. Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J 1996;13:250-6.
2. Naylor CD, Chen E. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: the Ontario experience, 1981 to 1991. J Am Coll Cardiol 1994;24:1431-8.
3. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, et al, for the Minnesota Heart Survey investigators. Recent trends in acute coronary heart disease. Mortality, morbidity, medical care and risk factors. N Engl J Med 1996;334:884-90.
4. Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, et al. Myocardial infarction patients in the 1990s- their risk factors, stratification and survival in Canada. The Canadian Assessment of Myocardial Infarction (CAMI) study. J Am Coll Cardiol 1996;27:1119-27.
5. GISSI (Gruppo Italiano per lo Studio Della Streptochinasi Nell'infarcto Mioccardio). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
6. ISIS-2 Second International Study of Infarct Survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither, among 17,817 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
7. ISIS-1 (First International Study of Infarct Survival) collaborative group. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1983;2:57-66.
8. Pfeffer MA, Braunwald E, Moya LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992;327:669-77.
9. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
10. O'Keefe JH Jr, Bailey WL, Rurtherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 1993;72:107G-15G.
11. Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction. Comparison of Q wave and non-Q wave myocardial infarction in the Framingham heart study. JAMA 1992;268:1545-51.
12. Behar S, Haim M, Hod H, Kornowski R, Reicher-Reiss H, Zion M, et al. Long-term prognosis of patients after a Q wave versus non-Q wave first acute myocardial infarction. Eur Heart J 1996;17:1532-7.
13. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Non-Q wave myocardial infarction: recent changes in occurrence and prognosis: a community wide perspective. Am Heart J 1987;113:273-9.
14. Chouchan L, Hajar HA, George T, Pomposiello JC. Non-Q and Q-wave infarction after thrombolytic therapy with intravenous streptokinase for chest pain and anterior ST segment elevation. Am J Cardiol 1991;68:446-50.
15. The Israeli SPRINT study group. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988;9:354-64.
16. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Standards and procedures for measurements and classification. Littleton (MA): John Wright; 1982.
17. LOGISTIC procedure. SAS/STAT User's guide, version 6, 4th ed, vol 1. Cary (NC): SAS Institute; 1989. p. 1077-126.
18. The PHREG procedure, preliminary documentation. SAS/STAT software. Cary (NC): SAS Institute; 1991. p. 1-59.
19. Matetzky S, Barabash GI, Rabinowitz B, Rath S, Har Zahav Y, et al. Q wave and non-Q wave myocardial infarction after thrombolysis. J Am Coll Cardiol 1995;26:1445-51.
20. Lamas GA, Pfeffer MA, Hamm P, Werthimer J, Rouleau JL, Braunwald E, et al, for the SAVE investigators. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992;327:241-7.
21. Braun S, Boyko V, Behar S, Reicher-Reiss H, Shotan A, Schlesinger Z, et al. Bezafibrate Infarction Prevention Study Participants. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol 1996;28:7-11.
22. Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med 1986;315:423-9.